A cluster of invasive meningococcal disease (IMD) caused by Neisseria meningitidis serogroup W among university students, France, February to May 2017

Between February and May 2017, two cases of invasive meningococcal disease caused by a new, rapidly expanding serogroup W meningococci variant were reported among students of an international university in Paris. Bacteriological investigations showed that isolates shared identical genotypic formula (W:P1.5,2:F1-1:cc11) and belonged to the South American/UK lineage. A vaccination campaign was organised that aimed at preventing new cases linked to potential persistence of the circulation of the bacteria in the students.
Source: Eurosurveillance - Category: Infectious Diseases Source Type: research

Related Links:

Publication date: Available online 11 September 2019Source: Molecular and Cellular ProbesAuthor(s): Hesam Dorosti, Mahboobeh Eslami, Navid Nezafat, Fardin Fadaei, Younes GhasemiAbstractStreptococcus pneumoniae is the main cause of diseases such as meningitis, pneumoniae and sepsis, especially in children and old people. Due to costly antibiotic treatment, and increasing resistance of pneumococcus, developing high-efficient protective vaccine against this pathogen is an urgent need. Although the pneumoniae polysaccharide vaccine (PPV) and pneumonia conjugate vaccines (PCV) are the efficient pneumococcal vaccine in children ...
Source: Molecular and Cellular Probes - Category: Molecular Biology Source Type: research
This report surveyed vaccination coverage among adolescents in the United States, with a special emphasis on HPV vaccine and meningococcal vaccine.Morbidity &Mortality Weekly Report
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Public Health & Prevention Journal Article Source Type: news
Condition:   Meningococcal Infection (Healthy Volunteers) Interventions:   Biological: Meningococcal polysaccharide (serogroups A, C, Y, and W) tetanus toxoid conjugate vaccine MenACYW conjugate vaccine;   Biological: Meningococcal Group B Vaccine (Trumenba®);   Biological: Meningococcal group B Vaccine (Bexsero®) Sponsor:   Sanofi Pasteur, a Sanofi Company Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Purpose of review This review highlights the recent impacts of vaccines against the major bacterial causes of meningitis in children, and the challenges for further prevention of bacterial meningitis, with a focus on Streptococcus pneumoniae, Neisseria meningitidis and group B Streptococcus. Recent findings Conjugate vaccines against S. pneumoniae and N. meningitidis have resulted in dramatic reductions in bacterial meningitis globally where they have been used. Recent licensure and use of capsular group B meningococcal protein vaccines have further reduced meningococcal meningitis in infants, young children and adole...
Source: Current Opinion in Infectious Diseases - Category: Infectious Diseases Tags: PAEDIATRIC AND NEONATAL INFECTIONS: Edited by Saul N. Faust Source Type: research
Neisseria meningiditis (Nm) is a commensal bacterium that can cause severe infections which are collectively known as meningococcal disease. Effective vaccines are important for disease control and prevention.1 During 2009-2014, 4109 cases of meningococcal disease were reported in the United States, with serogroups B, C and Y accounting for the majority of cases.2,3 Quadrivalent meningococcal polysaccharide conjugate vaccine (MenACWY) was recommended for adolescents aged 11 –18 years in the United States in 2005 to protect against disease caused by Nm serogroups A, C, W and Y.
Source: Journal of Infection - Category: Infectious Diseases Authors: Source Type: research
This study is the first to report on the involvement of Cas9 in the regulation and pathogenesis of R. anatipestifer, and provides a theoretical basis for the development of relevant genetic engineering vaccines.
Source: Microbial Pathogenesis - Category: Infectious Diseases Source Type: research
Source: Human Vaccines and Immunotherapeutics - Category: Allergy & Immunology Authors: Source Type: research
This study demonstrates that formalin treatment increases the stability and immunogenicity of CVB1-VLP vaccine and may offer a universal tool for the stabilization of VLPs in the production of more efficient vaccines.
Source: Antiviral Therapy - Category: Virology Source Type: research
Authors: Roden RC, Oholendt K, Lange H, Noritz G, Bonny AE Abstract PURPOSE: Assessing provider adherence to preventative sexual and reproductive healthcare guidelines in adolescents and young adults (AYA) patients with physical and intellectual disabilities (PWD). METHODS: Records of PWD (N= 42) age 12-26 receiving health maintenance between 01/01/11-12/31/16 were reviewed for: (1) initiation and completion of human papilloma virus (HPV) vaccination series, (2) initiation and completion of meningococcal vaccination, (3) screening for human immunodeficiency virus (HIV), and documentation of (4) sexual, (5) mens...
Source: Journal of Pediatric Rehabilitation Medicine - Category: Rehabilitation Tags: J Pediatr Rehabil Med Source Type: research
Publication date: Available online 2 September 2019Source: Journal of Microbiological MethodsAuthor(s): Ali Pormohammad, Taher Azimi, Seyedeh Marzieh Jabbari Shiadeh, Ghazaleh Talebi, Ali Hashemi, Elham Abbasi, Fatemeh FallahAbstractThe present study aimed to design a sensitive, specific and rapid multiplex real-time PCR for detection of the common causative agents of meningitis. Also, we aimed to report valuable genotyping data from Iran for establishing future vaccination and prevention strategies for the meningitis. From July 2015 to January 2018, 325 suspected cases of meningitis were enrolled in the current study. Uni...
Source: Journal of Microbiological Methods - Category: Microbiology Source Type: research
More News: France Health | Men | Meningitis | Meningitis Vaccine | Students | Universities & Medical Training | Vaccines